|
|
Volumn 30, Issue 8, 2012, Pages 729-730
|
|
Cautious optimism surrounds early clinical data for PD-1 blocker.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMMUNOGLOBULIN G;
MONOCLONAL ANTIBODY;
PDCD1 PROTEIN, HUMAN;
PROGRAMMED DEATH 1 RECEPTOR;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
DRUG INDUSTRY;
HUMAN;
IMMUNOLOGY;
METABOLISM;
NEOPLASM;
NOTE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
HUMANS;
IMMUNOGLOBULIN G;
NEOPLASMS;
PROGRAMMED CELL DEATH 1 RECEPTOR;
|
|
EID: 84873494926
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0812-729 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
